Published in:
Volume 6 / Year 2017 / Issue 4

Biosimilars in Germany: guidance of the Drug Commission of the German Medical Association

Author(s): ,
Page: 178-80

Abstract: Biosimilars have been available in Europe for more than 10 years, but their adoption in Germany has not been very successful. As their pharmaceutical quality, efficacy (particularly in extrapolated… Read More »

Go Back Print